Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

ClinicalTrials.gov ID: NCT02136914

Public ClinicalTrials.gov record NCT02136914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study)

Study identification

NCT ID
NCT02136914
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Adamas Pharmaceuticals, Inc.
Industry
Enrollment
126 participants

Conditions and interventions

Interventions

  • ADS-5102 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
30 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Nov 30, 2015
Completion
Nov 30, 2015
Last update posted
Feb 5, 2018

2014 – 2015

United States locations

U.S. sites
43
U.S. states
21
U.S. cities
40
Facility City State ZIP Site status
Not listed Birmingham Alabama 35233
Not listed Phoenix Arizona 85013
Not listed Scottsdale Arizona 85259
Not listed Sun City Arizona 85351
Not listed Fountain Valley California 92708
Not listed Pasadena California 91105
Not listed Reseda California 91335
Not listed Sacramento California 95817
Not listed Torrance California 90505
Not listed Ventura California 93003
Not listed Aurora Colorado 80045
Not listed Manchester Connecticut 06040
Not listed Boca Raton Florida 33486
Not listed Gainesville Florida 32607
Not listed Naples Florida 34102
Not listed Port Charlotte Florida 33980
Not listed Sunrise Florida 33351
Not listed Tampa Florida 33613
Not listed Weston Florida 33331
Not listed Atlanta Georgia 30329
Not listed Chicago Illinois 60612
Not listed Des Moines Iowa 50309
Not listed Kansas City Kansas 66160
Not listed Bingham Farms Michigan 48025
Not listed West Bloomfield Michigan 48322
Not listed Golden Valley Minnesota 55427
Not listed St Louis Missouri 63110
Not listed Albany New York 12208
Not listed Commack New York 11725
Not listed New York New York 10003
Not listed New York New York 10016
Not listed New York New York 10029
Not listed Raleigh North Carolina 27607
Not listed Cincinnati Ohio 45219
Not listed Cleveland Ohio 44195
Not listed Toledo Ohio 43614
Not listed Tulsa Oklahoma 74136
Not listed Philadelphia Pennsylvania 19107
Not listed Dallas Texas 75390
Not listed Houston Texas 77030-1
Not listed Houston Texas 77030-2
Not listed Kirkland Washington 98034
Not listed Milwaukee Wisconsin 53233

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02136914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 5, 2018 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02136914 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →